Cargando…

Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice

BACKGROUND: Little is known regarding the toxic and therapeutic doses of amygdalin. Treatment regimens and schedules can vary between humans and animal models, and there have been reports of cyanide toxicity due to amygdalin use. OBJECTIVE: The aim of this study was to evaluate the effect of differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Albogami, Sarah, Hassan, Aziza, Ahmed, Nibal, Alnefaie, Alaa, Alattas, Afnan, Alquthami, Lama, Alharbi, Afaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246030/
https://www.ncbi.nlm.nih.gov/pubmed/32509470
http://dx.doi.org/10.7717/peerj.9232
_version_ 1783537868888604672
author Albogami, Sarah
Hassan, Aziza
Ahmed, Nibal
Alnefaie, Alaa
Alattas, Afnan
Alquthami, Lama
Alharbi, Afaf
author_facet Albogami, Sarah
Hassan, Aziza
Ahmed, Nibal
Alnefaie, Alaa
Alattas, Afnan
Alquthami, Lama
Alharbi, Afaf
author_sort Albogami, Sarah
collection PubMed
description BACKGROUND: Little is known regarding the toxic and therapeutic doses of amygdalin. Treatment regimens and schedules can vary between humans and animal models, and there have been reports of cyanide toxicity due to amygdalin use. OBJECTIVE: The aim of this study was to evaluate the effect of different doses of amygdalin on antioxidant gene expression and suppression of oxidative damage in mice. METHODS: Forty adult male mice were divided randomly into four groups (n = 10) as follows and treated orally for two weeks: a control group treated with saline solution, a group treated with amygdalin at 200 mg/kg body weight, a group treated with amygdalin at 100 mg/kg body weight, and a group treated with amygdalin at 50 mg/kg body weight. Liver and testis samples were collected for gene expression, biochemical and histopathological analyses. RESULTS: The mice treated with medium-dose amygdalin (100 mg/kg) showed upregulated mRNA expression of glutathione peroxidase (P < 0.01) and superoxide dismutase (P < 0.05) and significantly decreased lipid peroxidation (P < 0.05) in hepatic and testicular tissues compared to those in the untreated groups (controls), with mild histopathological effects. The mice treated with high-dose of amygdalin (200 mg/kg) showed downregulated mRNA expression of glutathione peroxidase and superoxide dismutase (P < 0.01) and significantly increased lipid peroxidation (P < 0.05) in both hepatic and testicular tissues compared to those in the untreated groups (controls), with an apparent effect at the histopathological level. No effects were observed in the mice treated with low-dose amygdalin (50 mg/kg) at the gene, protein and histopathological level. CONCLUSION: Low-and medium-dose amygdalin did not induce toxicity in the hepatic and testicular tissues of male mice, unlike high-dose amygdalin, which had a negative effect on oxidative balance in mice. Therefore, amygdalin at a moderate dose may improve oxidative balance in mice.
format Online
Article
Text
id pubmed-7246030
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-72460302020-06-04 Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice Albogami, Sarah Hassan, Aziza Ahmed, Nibal Alnefaie, Alaa Alattas, Afnan Alquthami, Lama Alharbi, Afaf PeerJ Biotechnology BACKGROUND: Little is known regarding the toxic and therapeutic doses of amygdalin. Treatment regimens and schedules can vary between humans and animal models, and there have been reports of cyanide toxicity due to amygdalin use. OBJECTIVE: The aim of this study was to evaluate the effect of different doses of amygdalin on antioxidant gene expression and suppression of oxidative damage in mice. METHODS: Forty adult male mice were divided randomly into four groups (n = 10) as follows and treated orally for two weeks: a control group treated with saline solution, a group treated with amygdalin at 200 mg/kg body weight, a group treated with amygdalin at 100 mg/kg body weight, and a group treated with amygdalin at 50 mg/kg body weight. Liver and testis samples were collected for gene expression, biochemical and histopathological analyses. RESULTS: The mice treated with medium-dose amygdalin (100 mg/kg) showed upregulated mRNA expression of glutathione peroxidase (P < 0.01) and superoxide dismutase (P < 0.05) and significantly decreased lipid peroxidation (P < 0.05) in hepatic and testicular tissues compared to those in the untreated groups (controls), with mild histopathological effects. The mice treated with high-dose of amygdalin (200 mg/kg) showed downregulated mRNA expression of glutathione peroxidase and superoxide dismutase (P < 0.01) and significantly increased lipid peroxidation (P < 0.05) in both hepatic and testicular tissues compared to those in the untreated groups (controls), with an apparent effect at the histopathological level. No effects were observed in the mice treated with low-dose amygdalin (50 mg/kg) at the gene, protein and histopathological level. CONCLUSION: Low-and medium-dose amygdalin did not induce toxicity in the hepatic and testicular tissues of male mice, unlike high-dose amygdalin, which had a negative effect on oxidative balance in mice. Therefore, amygdalin at a moderate dose may improve oxidative balance in mice. PeerJ Inc. 2020-05-21 /pmc/articles/PMC7246030/ /pubmed/32509470 http://dx.doi.org/10.7717/peerj.9232 Text en © 2020 Albogami et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Biotechnology
Albogami, Sarah
Hassan, Aziza
Ahmed, Nibal
Alnefaie, Alaa
Alattas, Afnan
Alquthami, Lama
Alharbi, Afaf
Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
title Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
title_full Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
title_fullStr Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
title_full_unstemmed Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
title_short Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
title_sort evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
topic Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246030/
https://www.ncbi.nlm.nih.gov/pubmed/32509470
http://dx.doi.org/10.7717/peerj.9232
work_keys_str_mv AT albogamisarah evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice
AT hassanaziza evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice
AT ahmednibal evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice
AT alnefaiealaa evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice
AT alattasafnan evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice
AT alquthamilama evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice
AT alharbiafaf evaluationoftheeffectivedoseofamygdalinfortheimprovementofantioxidantgeneexpressionandsuppressionofoxidativedamageinmice